Galimberti, Marco http://orcid.org/0000-0001-6052-156X
Levey, Daniel F. http://orcid.org/0000-0001-8431-9569
Deak, Joseph D. http://orcid.org/0000-0002-0540-6080
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Stein, Murray B. http://orcid.org/0000-0001-9564-2871
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (R01 AA026364)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01 DA054869, R01 DA058862)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse
U.S. Department of Veterans Affairs (I01CX001849-01)
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (R21 CA252916)
Article History
Received: 5 January 2024
Revised: 25 March 2024
Accepted: 28 March 2024
First Online: 5 April 2024
Competing interests
: JG is named as an inventor on PCT patent application #15/878,640 entitled: “Genotype-guided dosing of opioid agonists,” filed January 24, 2018 and issued on January 26, 2021 as U.S. Patent No. 10,900,082. JG is paid for editorial work for the journal “Complex Psychiatry.” MBS has in the past 3 years received consulting income from Acadia Pharmaceuticals, Aptinyx, atai Life Sciences, BigHealth, Bionomics, BioXcel Therapeutics, Boehringer Ingelheim, Clexio, Eisai, EmpowerPharm, Engrail Therapeutics, Janssen, Jazz Pharmaceuticals, NeuroTrauma Sciences, PureTech Health, Sumitomo Pharma, and Roche/Genentech. MBS has stock options in Oxeia Biopharmaceuticals and EpiVario. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America.